Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Review
Nanobiotechnology
Contents   Editorial   News Feature Features
Perspectives Reviews Careers Feedback


Nature Biotechnology  21, 1184 - 1191 (2003)
Published online: 30 September 2003; | doi:10.1038/nbt876

Small-scale systems for in vivo drug delivery

David A LaVan1, Terry McGuire2 & Robert Langer3

1  Department of Mechanical Engineering, Yale University, New Haven, Connecticut 06520-8284, USA.

2  Polaris Venture Partners, 1000 Winter Street, Waltham, Massachusetts 02451, USA.

3  Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

Correspondence should be addressed to Robert Langer rlanger@mit.edu
Recent developments in the application of micro- and nanosystems for drug administration include a diverse range of new materials and methods. New approaches include the on-demand activation of molecular interactions, novel diffusion-controlled delivery devices, nanostructured 'smart' surfaces and materials, and prospects for coupling drug delivery to sensors and implants. Micro- and nanotechnologies are enabling the design of novel methods such as radio-frequency addressing of individual molecules or the suppression of immune response to a release device. Current challenges include the need to balance the small scale of the devices with the quantities of drugs that are clinically necessary, the requirement for more stable sensor platforms, and the development of methods to evaluate these new materials and devices for safety and efficacy.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
TIMELINE: Moving smaller in drug discovery and delivery
Nature Reviews Drug Discovery Perspective (01 Jan 2002)
 See all 3 matches for Reviews

NEWS AND VIEWS
Drug delivery: Pulsed polymers
Nature Materials News and Views (01 Nov 2003)
Silicon membranes: A microscale Brownian ratchet
Nature Materials News and Views (01 Aug 2003)
 See all 6 matches for News And Views

RESEARCH
High-aspect-ratio bulk micromachining of titanium
Nature Materials Letters (01 Feb 2004)
The 'right' size in nanobiotechnology
Nature Biotechnology Research (01 Oct 2003)
 See all 3 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy